story of the week
Long-Term Effectiveness and Safety of Rituximab in NMOSD and MOGAD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease
Neurology 2022 Nov 29;99(22)e2504-e2516, P Barreras, ES Vasileiou, AG Filippatou, KC Fitzgerald, M Levy, CA Pardo, SD Newsome, EM Mowry, PA Calabresi, ES SotirchosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.